Work

Consensus of Chinese Experts on the Diagnosis and Treatment of Type Ⅰ Interferonopathy

Year: 2024

Type: article

Abstract: Type Ⅰ interferonopathy is an autoinflammatory disease that affects multiple systems, with a high disability and mortality rate. It profoundly impacts the quality of life of patients and poses a considerable burden on their families and society. Due to the broad spectrum of clinical phenotypes associated with this condition, early identification remains challenging. Delays in diagnosis and treatment can exacerbate the disease, making it difficult to reverse the conditions and adversely affecting the prognosis. Therefore, the Chinese Alliance of Pediatric Rheumatic & Immunologic Diseases and Chinese Pharmacists Association Rare Diseases Medication Working Committee has developed this consensus document to offer detailed recommendations pertaining to the definition, genetic categorization, clinical presentations, diagnostic approaches, and therapeutic management of type Ⅰ interferonopathy.

Source: DOAJ (DOAJ: Directory of Open Access Journals)

DOI: 10.12376/j.issn.2097-0501.2024.04.010

Authors: Chinese Alliance of Pediatric Rheumatic & Immunologic Diseases, Chinese Pharmacists Association Rare Diseases Medication Working Committee

Institutions: Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital

Language: English

Topic: interferon and immune responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W6959720927

FWCI:

Cites:

Cited by:

Related to: